Aranesp, Epogen & Procrit Death, Heart Attack, Stroke, and Blood Clots
On March 9, 2007 the FDA announced that these anemia drugs are associated with increased rates of death, heart attack, stroke, and blood clots. Specifically, the FDA said:
Patients with chronic kidney failure had an increased number of deaths and of non-fatal heart attacks, strokes, heart failure, and blood clots when ESAs were adjusted to maintain higher red blood cell levels (hemoglobin more than 12 g/dL).
Patients with head and neck cancer receiving radiation therapy had faster tumor growth when ESAs were adjusted to maintain hemoglobin levels higher than 12 g/dL.
Patients with cancer not receiving chemotherapy died sooner and had no fewer blood transfusions when ESAs were given according to the dosing recommendations for cancer patients receiving chemotherapy.
Patients scheduled for orthopedic surgery who received ESAs to reduce blood transfusions during and after surgery had more blood clots than those not given an ESA.
Aranesp, Epogen & Procrit Lawsuits
If a loved one died, or if you or a loved one suffered a heart attack, stroke, or blood clot while using any of these products, you may be entitled to compensation. Recovery may include past and future medical bills, pain and suffering and, if your loved one died, compensation for the loss of his or her companionship.
To find out if you have a claim, Please call us now at 1-888-552-5247 or fill out the form at right for a free consultation.
Experienced Aranesp, Epogen & Procrit Lawyers
Unlike the vast majority of law firms advertising for pharmaceutical injuries, we have actually tried pharmaceutical cases to verdict. Mr. Blair has prepared hundreds of pharmaceutical cases to trial and settled thousands of claims for people injured by drug company greed. If you want a lawyer with experience litigating pharmaceutical claims, as opposed to merely advertising, call us now.